GROUP ONE TRADING, L.P. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 170 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,272100
+9900.0%
0.00%
Q2 2022$0
-100.0%
1
-100.0%
0.00%
Q1 2022$119,000
-48.0%
12,830
-45.2%
0.00%
Q4 2021$229,000
+151.6%
23,424
+770.1%
0.00%
Q3 2021$91,000
-14.2%
2,692
-7.4%
0.00%
Q2 2021$106,000
-27.9%
2,907
+12.5%
0.00%
Q4 2020$147,000
+37.4%
2,584
-0.9%
0.00%
-100.0%
Q1 2020$107,000
-85.6%
2,607
-78.2%
0.00%
-80.0%
Q4 2019$743,000
+143.6%
11,937
+32.8%
0.01%
+150.0%
Q3 2019$305,000
+771.4%
8,990
+898.9%
0.00%
Q3 2018$35,0009000.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$18,687,87215.44%
Redmile Group, LLC 5,582,105$86,243,5223.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,218,638$80,627,9571.80%
BRAIDWELL LP 3,241,351$50,078,8731.65%
Parkman Healthcare Partners LLC 491,772$7,597,8771.65%
Sunesis Advisors, LLC 96,299$1,487,8201.07%
ARMISTICE CAPITAL, LLC 4,100,000$63,345,0000.91%
Deep Track Capital, LP 1,363,201$21,061,4550.86%
AlphaCentric Advisors LLC 72,500$1,120,1250.77%
Ikarian Capital, LLC 174,510$2,696,1790.61%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders